Overexpression of TP53 is associated with poor survival, but not with reduced response to hypomethylating agents in older patients with acute myeloid leukaemia
Lieke H. van der Helm; Gerbrig Berger; Arjan Diepstra; Gerwin Huls; Edo Vellenga
Author Information: Department of Haematology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.